Home / Sweden / RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ)
Short position disclosed on August 11, 2026.
4.15% of the capital sold short
5 disclosing funds
207 disclosures on record
SE0000135485 ISIN code
Evolution of the disclosed total
0%2%4%6%
Oct 2025Jan 2026Apr 2026Jul 2026
August 20, 2017 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| JPMorgan Asset Management (UK) Ltd | 1.08% | new | July 17, 2026 | |
| Connor Clark & Lunn Investment Management Ltd. | 1.00% | new | July 23, 2026 | |
| GSA Capital Partners LLP | 0.89% | new | August 11, 2026 | |
| D E Shaw Co LP | 0.68% | new | July 31, 2026 | |
| Tudor Capital Europe LLP | 0.50% | new | August 7, 2026 |
On the other side: the funds that hold RaySearch Laboratories AB (publ) Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 28, 2017 | BlackRock Investment Management (UK) Limited | 0.61% | still open |
| August 24, 2017 | JPMorgan Asset Management (UK) Ltd | 0.72% | still open |
| August 23, 2017 | JPMorgan Asset Management (UK) Ltd | 0.72% | still open |
| August 22, 2017 | JPMorgan Asset Management (UK) Ltd | 0.60% | still open |
| August 21, 2017 | JPMorgan Asset Management (UK) Ltd | 0.60% | still open |
| August 21, 2017 | BlackRock Investment Management (UK) Limited | 0.51% | still open |
| August 20, 2017 | BlackRock Investment Management (UK) Limited | 0.51% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.36% of the capital sold short
- Elekta AB (publ) 10.19% of the capital sold short
- JM AB 7.01% of the capital sold short
- Hemnet Group AB (publ) 6.08% of the capital sold short
- Bonesupport Holding AB 5.58% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Embracer Group AB 5.25% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- Dynavox Group AB 4.30% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
- Stillfront Group AB (publ) 3.75% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, RaySearch Laboratories AB (publ), source Finansinspektionen, data as at August 11, 2026, https://www.quivad.com/action/raysearch-laboratories-ab-publ?page=5